share_log

Veru Price Target Raised To $30 From $24 At Cantor Fitzgerald, Citing Sabizabulin Emergency Use Authorization Submission For Treatment Of COVID-19

Veru Price Target Raised To $30 From $24 At Cantor Fitzgerald, Citing Sabizabulin Emergency Use Authorization Submission For Treatment Of COVID-19

Veru 的目标价格从 Cantor Fitzgerald 的 24 美元上调至 30 美元,理由是萨比扎布林提交了治疗 COVID-19 的紧急使用许可
Benzinga Real-time News ·  2022/08/11 12:48

Veru Price Target Raised To $30 From $24 At Cantor Fitzgerald, Citing Sabizabulin Emergency Use Authorization Submission For Treatment Of COVID-19

Veru 的目标价格从 Cantor Fitzgerald 的 24 美元上调至 30 美元,理由是萨比扎布林提交了治疗 COVID-19 的紧急使用许可

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发